The Orders Inflect, Aerospace Margin Bottoms, and Solstice Spins in a Week — Upgrading to Outperform on a De-Rated Setup Meeting a Turning Fundamental
Key Takeaways
- The demand signal inflected. Orders grew 22% organically to $11.9B, broad-based across all four segments with a book-to-bill above 1x (Aerospace 1.2x), lifting backlog to a record $39.1B (+14%). This is the strongest order print in years and the clearest evidence yet that the R&D-led growth reset is converting to bookings, not just spend.
- The central worry from our July initiation resolved. Aerospace margin came in at 26.1%, up 60bp sequentially, and management explicitly confirmed that Q2's 25.5% was the trough and Aero is positioned to expand margins through 2026 as CAES turns accretive, commercial-OE shipments recouple, and the tariff-pricing lag closes. Organic Aero growth returned to double digits (+12%).
- Honeywell beat and raised for the third consecutive quarter. Revenue of $10.41B (+6% organic) topped the $10.1B Street number; adjusted EPS of $2.82 (+9%) crushed the $2.50-2.60 guide and the $2.56 consensus by 10%. The full-year adjusted EPS guide went up to $10.60-10.70 even while absorbing the ~$0.21 Solstice-spin drag.
- The value-unlock catalyst is now in motion. Solstice Advanced Materials (SOLS) begins trading October 30, a quarter ahead of the original schedule; a new simplified four-segment structure takes effect Q1 2026; the Aerospace spin remains on track for H2 2026 with a leadership and headquarters announcement due later this year; and the balance sheet was materially de-risked (Bendix asbestos divested, Resideo indemnification terminated for $1.6B cash).
- Rating: Upgrading to Outperform from Hold. Our July Hold was conditioned on seeing Aerospace margin prove transitory and the split value crystallize before paying up. Both happened. Meanwhile the stock has done the opposite of the fundamentals: it entered this print down 13.8% YTD against an S&P up 13.9% (a ~28-point relative underperformance) at ~19.5x forward, its cheapest multiple in years. A turning fundamental, an inflecting order book, and an imminent value-unlock at a de-rated price is the setup we said we were waiting for.
Results vs. Consensus
Q3 2025 Scorecard
| Metric | Q3 2025 Actual | Consensus / Guide | Beat/Miss | Magnitude |
|---|---|---|---|---|
| Revenue | $10.41B | $10.1B | Beat | +~$0.3B (+2.4%) |
| Organic sales growth | +6% | +2% to +4% (guide) | Beat | Above high end |
| Adjusted EPS | $2.82 | $2.56 (guide $2.50-2.60) | Beat | +$0.26 (+10.2%) |
| GAAP EPS | $2.86 | n/a | +32% YoY | One-time gains |
| Orders | $11.9B (+22%) | n/a | Inflection | Book-to-bill >1x |
| Backlog | $39.1B (+14%) | n/a | Record | n/a |
| Segment margin | ~23% (met high end) | Guide high end | In line | Segment profit +5% |
| Free cash flow | $1.5B | n/a | −16% YoY | Capex/WC timing |
| Effective tax rate | 19% | 20% prior | +$0.13 EPS | n/a |
Year-Over-Year Comparison
| Metric | Q3 2025 | Q3 2024 | YoY Change |
|---|---|---|---|
| Revenue | $10.41B | ~$9.73B | +7% reported / +6% organic |
| GAAP EPS | $2.86 | ~$2.16 | +32% (one-time gains) |
| Adjusted EPS | $2.82 | ~$2.58 | +9% |
| Segment profit | — | — | +5% |
| Orders | $11.9B | ~$9.8B | +22% organic |
| Backlog | $39.1B | ~$34.3B | +14% |
Quality of Beat
Revenue: The +6% organic figure is a genuine acceleration from Q2's +5%, and this time it is not obviously timing-flattered. Aerospace returned to double-digit organic growth (+12%), Building Automation posted its fourth straight high-single-digit quarter, and even Industrial Automation flipped positive (+1%, its first organic growth in roughly two years). The only soft spot was ESS (−2%) on UOP licensing and catalyst delays, which management characterizes as timing rather than demand.
Margins: Segment margin met the high end of guidance with segment profit up 5%, and the composition improved where it mattered most: Aerospace margin rose 60bp sequentially to 26.1%. The full-year segment-margin guide was nudged modestly lower again (on catalyst/licensing mix and short-cycle IA), so this is not yet a margin-expansion quarter. But the inflection point, Aero bottoming and turning up, is the pivot the bull case needed, and management now frames 2026 as the year margin expansion returns across the portfolio.
EPS: Adjusted EPS of $2.82 (+9%) beat by 10%, helped by a lower 19% tax rate (+$0.13) and reduced below-the-line costs. GAAP EPS of $2.86 (+32%) exceeded adjusted, reflecting net one-time gains from the Resideo indemnification termination ($1.6B cash) and Bendix asbestos divestiture. Investors should read the GAAP jump as balance-sheet cleanup, not operating power, but the cleanup itself is strategically valuable: it removes legacy liabilities ahead of the spins.
Segment Performance
| Segment | Organic Growth | Segment Margin | Margin Δ YoY | Read |
|---|---|---|---|---|
| Aerospace Technologies | +12% | 26.1% | −160bp (but +60bp QoQ) | Growth reaccelerates, margin bottoms |
| Industrial Automation | +1% | 18.8% | −150bp | Back to growth; margin still soft |
| Building Automation | +7% | — | +80bp | Fourth straight HSD quarter |
| Energy & Sustainability Solutions | −2% | 24.5% | Flat | UOP timing; refrigerants strong |
Aerospace Technologies — The Turn Arrives
This is the segment that carries the upgrade. Aero grew 12% organically, with Commercial OE returning to growth as shipments recoupled to customer build rates, Defense & Space extending its run on ramping national-defense budgets and supply-chain healing, and Commercial Aftermarket strong (up roughly 19%) on supply-chain unlock. Orders grew strong double digits across all three end markets with a 1.2x book-to-bill, and past-due backlog remains above $2B even at elevated output. The margin outcome is the headline: 26.1%, up 60bp sequentially, with management stating outright that the Q2 trough is behind and 2026 sets up for margin expansion.
"2Q '25 was probably the bottom, and you should continue to see sequential improvements on margins going to 2026… on recoupling, I think that's largely behind us." — Mike Stepniak, SVP & CFO
Assessment: The thesis-critical variable turned. A standalone Aerospace re-approaching 26%+ margins with a record book-to-bill, a >$2B past-due backlog, and a fresh Gulfstream G300 engines-and-avionics win is exactly the premium asset the H2 2026 spin needs to command an aerospace multiple. The commercial-aftermarket strength (management expects moderation toward high-single-digit in Q4) is a modest normalization, not a reversal. We now grade the Q2 "transitory margin" commitment as delivered.
Building Automation — Still the Template
BA delivered its fourth consecutive high-single-digit quarter (+7% organic) with margin up 80bp, led by North America and the Middle East, and with Europe growing organically for a fourth straight quarter. Data centers, healthcare, and hospitality are the demand drivers, and management continues to frame BA as the operating template for the future pure-play automation company: high-growth verticals, installed-base mining, and new-product velocity.
"The BA just reinforces the overarching Honeywell strategy on how we are pivoting our business through higher growth and margin expansion. So they are ahead of the curve… we do expect 2026 to follow the trend line you have observed in BA in 2025." — Vimal Kapur, Chairman & CEO
Assessment: BA remains the single most valuable piece of the RemainCo automation entity and the clearest proof that reinvestment converts to durable growth. Its emerging data-center exposure (safety, security, and increasingly building-management, plus the LS ELECTRIC partnership) taps a secular tailwind from a low base. If the BA playbook generalizes to IA and Process Automation in 2026, the automation company earns a growth multiple.
Industrial Automation — Off the Bottom
IA returned to organic growth (+1%) for the first time in roughly two years, beating guidance, led by Sensing (aerospace, medical, industrial verticals). Margin fell 150bp to 18.8% on unfavorable mix and cost inflation, and management expects a modest Q4 top-line dip on tough comps and warehouse-order timing. The bigger story is structural: under the new Q1 2026 segmentation, IA becomes a focused product business (Sensing plus what remains after the PSS/Intelligrated review), positioned as a US-reshoring beneficiary.
Assessment: IA is turning, but slowly, and its margin remains the portfolio's weakest at high-teens. Management has good visibility to 2026 margin expansion (backlog, pricing, fixed-cost baselining), and the segmentation change plus a possible warehouse/PSS exit would leave a cleaner, higher-quality product business. Still a "show-me," but the direction is finally right.
Energy & Sustainability Solutions — The Timing Drag, With a 2026 Turn
ESS declined 2% organically as strong refrigerants performance (the future Solstice) was offset by UOP licensing and catalyst-delivery delays. Margin held flat at 24.5%, cushioned by a one-time government reimbursement for past legal costs. UOP orders rose 9%, LNG demand is robust, and management expects ESS to return to margin expansion in 2026 as catalyst volumes normalize. After Solstice spins, the remaining ESS/UOP business folds into the new Process Automation & Technology segment.
Assessment: ESS is the quarter's soft segment, but the softness is well-understood (catalyst timing, energy-CapEx caution) and the leading indicator (UOP orders +9%, LNG strength) points up. The £1.8B Johnson Matthey Catalyst deal (closing H1 2026) strengthens the franchise. We treat ESS as a 2026 recovery, not a structural problem.
Key Topics & Management Commentary
Overall Management Tone: Confident and increasingly specific about 2026, with the defensiveness of the Q2 call replaced by a forward-leaning posture. Management repeatedly framed the drags that pressured 2025 margins (Aero integration, tariff-pricing lag, catalyst timing) as transitory and identified 2026 as an inflection to portfolio-wide margin expansion. The tone shift from Q2 is real: three quarters ago the message was "we can defend the guide in a tough macro"; now it is "the order book has inflected and the setup for next year is strong." That shift is grounded in the +22% orders, not just rhetoric.
1. Orders +22%: The Growth Reset Shows Up in Bookings
The defining number of the quarter was orders, not EPS. A 22% organic increase to $11.9B, broad-based across all four segments with book-to-bill above 1x, is the first hard evidence that the R&D-led growth strategy (and the acquisitions) are converting to demand.
"I can't remember a quarter with 22% order growth… It's more across the board, Scott… Long cycle even stronger than short cycle, but short cycle is also growing… that's the foundation of the growth-oriented Honeywell we have been focusing on over the last 2 years." — Vimal Kapur, Chairman & CEO
Assessment: Orders are the leading indicator that revalidates the whole reinvestment thesis. A record $39.1B backlog de-risks 2026 revenue and hands each future standalone company a running start. This is the single most important data point for why the Hold becomes an Outperform: the growth we were told to wait for is now visible in the book.
2. Aerospace Margin: Commitment Delivered
Our Q2 initiation set the Aerospace margin as the highest-stakes graded commitment in the story. Q3 delivered: 26.1%, up 60bp sequentially, with the trough confirmed behind and a clear 2026 path (CAES accretion, OE recoupling, tariff-pricing catch-up).
"The confidence that we bottomed out in 25% margins in quarter 2, and then we are lapping towards 26% and higher, that direction is very clear." — Vimal Kapur, Chairman & CEO
Assessment: A standalone Aerospace whose margin is re-expanding into the spin is worth materially more than one whose margin is compressing. The market will underwrite the H2 2026 spin on the exit-rate margin, and Q3 moved that trajectory decisively in the right direction. This validates the premium-Aerospace pillar of our thesis.
2026 Pricing: The Margin Lever Resets
Management was explicit that pricing becomes a genuine tailwind in 2026 after a 2025 defined by a tariff-cost-vs-pricing lag. The teams have been working 2026 pricing plans for weeks, with Aerospace (which was behind on price in 2025) singled out as a segment that flips from headwind to tailwind.
"Pricing will become a good enabler for 2026 margin expansion. The only headwind we faced in pricing… in 2025 was just a lag effect… We are not going to face that event in 2026." — Vimal Kapur, Chairman & CEO
Assessment: This is the mechanical basis for the 2026 margin-expansion story. If the 2025 margin softness was substantially a timing lag (tariff cost hitting before price catches up), then 2026 should see the reverse, price realized against stabilizing cost. It is a credible, specific claim we can grade next year.
4. Solstice Spins October 30 — A Quarter Early
Solstice Advanced Materials (SOLS) begins trading October 30, roughly a quarter ahead of the original early-2026 target, following a well-attended Investor Day. It is the first of the three-way split to become concrete, and management explicitly plans to carry the execution learnings into the larger Aerospace separation.
"Barely a year since we announced our intent to separate Advanced Materials, today, we are a week out from Solstice's first day of trading as an independent company. Our swift progress to this point demonstrate our ability to diligently execute carefully crafted work plans with speed and efficacy." — Vimal Kapur, Chairman & CEO
Assessment: Execution ahead of schedule is the best possible de-risking signal for the far larger Aerospace spin in H2 2026. A management team that pulls a complex carve-out forward by a quarter without commercial disruption earns credibility on the harder separation to come. This is the value-unlock catalyst moving from promise to fact, exactly the crystallization we said would trigger an upgrade.
5. New Four-Segment Structure Effective Q1 2026
Management pre-announced a simplified segmentation effective Q1 2026: Aerospace Technologies, Building Automation, Process Automation & Technology (combining core Process Solutions and UOP), and Industrial Automation, organized into six strategic business units around a unified automation strategy and the Forge platform.
"This new structure serves as an elegant way to continue simplifying the RemainCo portfolio and align our external segment to the way we are increasingly driving our operation through consistent business models." — Vimal Kapur, Chairman & CEO
Assessment: Combining HPS and UOP into Process Automation & Technology is analytically sensible (shared process-market customers, two-in-a-box selling) and creates a cleaner story for each RemainCo piece. The realignment signals management is building the pure-play automation company deliberately rather than leaving whatever is left after Aerospace departs.
6. Balance-Sheet De-Risking: Bendix and Resideo
Honeywell divested its Bendix asbestos liability and terminated the Resideo indemnification and reimbursement agreement for $1.6B in cash, together producing a net cash inflow and removing two legacy overhangs. These are exactly the kind of pre-spin cleanups that make each standalone company more financeable.
"These transactions resulted in net cash inflow and will simplify and derisk our balance sheet, providing the company with fewer administrative burdens and greater financial flexibility." — Vimal Kapur, Chairman & CEO
Assessment: Removing the Bendix asbestos and Resideo liabilities is under-appreciated value creation. Legacy liabilities depress the multiple a market will pay for a spun entity; retiring them ahead of the separations directly supports the sum-of-the-parts case and improves each future company's balance-sheet quality.
7. Quantinuum: The Option Gets Bigger
Quantinuum raised a September round at roughly $10B (double the prior $5B pre-money), adding NVIDIA and Quanta alongside JPMorgan, Amgen, and Mitsui. Management reiterated it is not the long-term owner and will begin monetizing its stake at the appropriate time.
"Less than 2 years after completing an equity capital raise at a $5 billion pre-money valuation, the company announced in September a second raise at double the prior valuation… Honeywell will seek to begin monetizing its stake… in a manner that will create meaningful value for Honeywell shareowners." — Vimal Kapur, Chairman & CEO
Assessment: A doubling of the implied valuation with NVIDIA joining the cap table turns Quantinuum from a rounding-error option into a plausible source of surfaced value. It is not in our base-case valuation, but the eventual monetization is a real, and now larger, source of upside optionality.
Guidance & Outlook
| Metric | Prior FY25 Guide | New FY25 Guide | Change |
|---|---|---|---|
| Organic growth | +4% to +5% | ~+6% (5% ex-Bombardier) | Raised +150bp (midpoint) |
| Sales | $40.8–41.3B | $40.7–40.9B | Reshaped (Solstice out) |
| Segment margin | 23.0–23.2% | +30-40bp YoY | Modestly lower on mix |
| Adjusted EPS | $10.45–10.65 | $10.60–10.70 | Raised (3rd time) |
| Free cash flow | $5.4–5.8B | $5.2–5.6B | Solstice-adjusted (flat like-for-like) |
The raise is cleaner than Q2's. Organic growth guidance went up 150bp at the midpoint to ~6%, and adjusted EPS rose to $10.60-10.70, the third increase this year, achieved while absorbing the ~$0.21 Solstice-spin dilution (the spin also removes ~$700M of sales and ~$200M of FCF). On a like-for-like basis, free cash flow guidance is unchanged. The one soft note remains segment margin, nudged modestly lower again on catalyst/licensing mix and short-cycle IA, which keeps the full-blown margin-expansion story a 2026 event.
Q4 setup: Management guided Q4 organic growth of +8-10% (4-6% ex-Bombardier), sales of $10.1-10.3B, segment margin of 22.5-22.8%, and adjusted EPS of $2.52-2.62. The Q4 segment-margin guide implies year-over-year contraction ex-Bombardier (ESS catalyst timing and IA mix), reinforcing that the portfolio-wide margin turn is a 2026 story, front-run by the Aerospace inflection now.
2026 framing: Management is unusually explicit that 2026 is the margin-expansion year across Aerospace (pricing, CAES accretion, OE recoupling), Industrial Automation (backlog leverage, fixed-cost baselining), and ESS (catalyst normalization). Combined with the record backlog and the new segment structure, the setup into a "historic" 2026 (two spins, a pure-play automation company emerging) is the forward story the upgrade underwrites.
Analyst Q&A Highlights
Whether the 22% Order Growth Was Discrete or Broad-Based
The most important line of questioning tested whether the eye-popping order figure was a one-off lumpy project or a genuine broad inflection. Management was clear it was across the board, with long-cycle stronger than short-cycle but every segment growing.
Q: "I can't remember a quarter with 22% order growth… was there any kind of discrete projects or anything big that generally move the needle there? Or was it more across the board?"
— Scott Davis, Melius Research
A: "It's more across the board, Scott… Aero continues to do extremely well… ESS orders growth were very good and also in IA… Long cycle even stronger than short cycle, but short cycle is also growing. And I do expect the trend to continue in Q4."
— Vimal Kapur, Chairman & CEO
Assessment: The breadth is what makes it a thesis event rather than a data point. A single mega-project would be noise; broad-based, all-segment order acceleration with a >1x book-to-bill and a promise of continuation into Q4 is signal. This is the exchange that most supports the upgrade.
Whether the Aerospace Destocking Is Behind and 26% Is a Fair Placeholder
A recurring topic pressed on whether the commercial-OE destocking that pressured Q2 has cleared and whether 26% is a reasonable Aero margin base into 2026. Management confirmed the trough and the recoupling are behind, with sequential improvement ahead.
Q: "Maybe give us some update on where we stand on that destocking. Do you think it's largely behind you now on the commercial aero side? And should we assume that 26% margin rate is a good placeholder into next year?"
— Julian Mitchell, Barclays
A: "Super happy with how the Aero team performed… 2Q '25 was probably the bottom, and you should continue to see sequential improvements on margins going to 2026. And on recoupling, I think that's largely behind us… our past due backlog… continues to hang over $2 billion."
— Mike Stepniak, SVP & CFO
Assessment: Two graded Q2 commitments (margin trough, OE recoupling) both cleared. The >$2B past-due backlog is an under-appreciated forward-revenue cushion: Aero is output-constrained, not demand-constrained, which is a high-quality problem heading into the spin.
Whether Pricing Is an Untapped 2026 Margin Lever
An analyst probed whether revenue rising while margins slipped in 2025 implied a pricing opportunity being left on the table. Management reframed 2025's margin softness as a tariff-pricing lag that reverses in 2026.
Q: "Revenue expectations are increasing, margin expectations are coming down a little bit… just wanted to understand if there's maybe a pricing opportunity in the future that is not being exploited today."
— Amit Mehrotra, UBS
A: "If I look ahead in 2026, pricing will become a good enabler for 2026 margin expansion. The only headwind we faced in pricing… in 2025 was just a lag effect… We are not going to face that event in 2026… Aero was behind on price this year. It's going to be a tailwind for them next year."
— Vimal Kapur, Chairman & CEO
Assessment: This is the clearest articulation of why 2026 margins should expand: 2025 absorbed the cost inflation before the price caught up, and 2026 harvests the reverse. It is a specific, checkable claim. If Aero and the short-cycle businesses realize price against stabilizing cost, the margin-expansion guide has a mechanical basis rather than a hopeful one.
The ESS Fourth-Quarter Margin Dip
A recurring line of questioning dug into the implied 3-4 point year-over-year ESS margin decline in Q4 and whether the Solstice loss and catalyst push-outs were structural. Management framed it as seasonality and timing, with a 2026 recovery.
Q: "The 4Q margin for ESS… implies 3 to 4 points of decline year-over-year… is the Advanced Materials Solstice spin, losing 2 months of that, having a material impact?"
— Nigel Coe, Wolfe Research
A: "We see a little bit of transitory… softness in margins, and that's predominantly driven by mix. So we see catalyst pushouts to continue… ESS will normalize, as we progress through 2026, back to its historical margins… we expect ESS margin to expand in 2026."
— Mike Stepniak / Vimal Kapur
Assessment: The ESS Q4 dip is the least clean part of the guide, and the "seasonality plus an unusually strong Q2 pull-forward" framing is credible but self-serving. UOP orders up 9% and robust LNG demand support the 2026-recovery claim; catalyst timing is the swing factor to watch. Not a thesis risk, but the segment we are least sure about.
Whether Further Portfolio Actions Are Coming Before the Aero Spin
An analyst asked whether the neat new four-segment structure implied more portfolio moves ahead of the H2 2026 Aerospace separation. Management reiterated the major review is complete, with only bolt-ons expected.
Q: "As we head into the Aero spin in the second half of '26, could you potentially see additional announcements on the portfolio?"
— Joe Ritchie, Goldman Sachs
A: "Based on the current portfolio assessment, actions we have done, they are completed… I do expect us to do more additions, which are bolt-on… I don't see that there will be any material change we want to make on what we own."
— Vimal Kapur, Chairman & CEO
Assessment: A stable portfolio is what each future company needs to present a clean investment case. The consistency between the Q2 and Q3 "review complete" message (aside from the still-open PSS/Intelligrated decision) is a credibility marker. The M&A posture is now bolt-on and tuck-in, which reduces integration and balance-sheet risk into the spins.
Pension Accounting and Income-Statement Simplification
A pointed question raised whether Honeywell would change its pension accounting and income-statement presentation ahead of the Aerospace spin to improve cash-to-earnings visibility. Management confirmed it is actively on the 2026 agenda without committing to specifics.
Q: "Any thoughts around changing the pension accounting and how you're reflecting that in your income statement? Is that something that could happen before Aerospace goes?"
— Steve Tusa, JPMorgan
A: "It's definitely on one of our agenda items as we go over into 2026… we'll continue to simplify our balance sheet and how we report earnings to make sure you have a better visibility to cash flow conversion and EPS."
— Mike Stepniak, SVP & CFO
Assessment: A pension-accounting change (moving non-service pension income out of the operating result) would reduce a long-standing quality-of-earnings criticism of Honeywell and make the standalone entities cleaner to value. It is a small but real governance positive to track into 2026.
What They're NOT Saying
- Still no standalone Aerospace financial framework. Leadership and headquarters are coming "later this year," but the standalone margin/growth/capital-structure disclosure that would let the market underwrite the spin remains outstanding. Until it lands, the SOTP value is our estimate, not the company's.
- Stranded and dis-synergy costs remain unquantified. Three quarters into the separation narrative, management still has not put a number on the corporate costs that get duplicated or stranded across three entities, the single largest swing factor in whether the SOTP math clears.
- The PSS/Intelligrated review is still open. Management again deferred a decision, now to the Q1 2026 call. A divestiture versus retention materially changes the automation RemainCo's growth and margin profile; the open-endedness persists.
- The GAAP-over-adjusted gap is a one-time gain, not earnings power. GAAP EPS of $2.86 exceeding adjusted $2.82 is entirely the Resideo/Bendix cleanup; it should not be read as underlying momentum, and management did not dwell on the distinction.
- Free cash flow is still not converting. FCF fell 16% on capex and working-capital timing, and the 90%+ conversion goal remains a 2026 target. The order strength has not yet shown up in cash.
- Q4 margin still contracts ex-Bombardier. The 22.5-22.8% Q4 segment-margin guide implies year-over-year contraction excluding Bombardier. The margin-expansion story is entirely a 2026 promise; Q4 does not yet show it outside Aerospace.
Market Reaction
- Pre-print setup: HON closed at $194.66 on October 22, down 13.8% YTD against an S&P up 13.9% (a ~28-point relative underperformance), down 11.7% over the trailing 12 months and 7.0% over the trailing 30 days. The stock entered the print de-rated and out of favor, mid-range in its $182.86-$240.40 52-week band.
- Reaction session (October 23, before-open reporter): Gapped up 4.1% at the open ($202.57) and closed at $207.91, up 6.8% ($13.25), on 10.0M shares versus a 4.7M 30-day average (2.2x volume).
- Market context: The S&P 500 rose 0.6% on the session, so the move was overwhelmingly company-specific.
A 6.8% rally is the mirror image of the Q2 sell-off, and the driver is the same variable read in reverse: quality. In Q2 the market punished a timing-aided beat with a cut margin guide; in Q3 it rewarded an order-led beat, a bottoming Aerospace margin, and an imminent value-unlock. The de-rated starting point amplified the move, a stock down 14% YTD with negative positioning has more room to re-rate on good news than one priced for perfection. The give-back is that some of the gain is a relief rally off depressed levels; the durable question is whether 2026 delivers the margin expansion management has now promised repeatedly. We think the order book and the pricing reset make that promise credible.
Street Perspective
Debate: Is the YTD De-Rating an Opportunity or a Value Trap?
Bull view: HON underperformed the S&P by ~28 points YTD despite a business that is accelerating (orders +22%, organic +6%, Aero margin turning). At ~19.5x forward, the cheapest in years, the market is paying nothing for the SOTP unlock and pricing in a permanence to the 2025 margin softness that management is dismantling. The de-rating is the setup, not the verdict.
Bear view: The de-rating reflects real concerns: a multi-year breakup with unquantified dis-synergies, sub-90% cash conversion, an energy/catalyst macro overhang, and a company whose "clean" growth (ex-Bombardier) is still only mid-single-digit. Cheap can stay cheap while the separation distraction plays out through H2 2026.
Our take: Opportunity. The order inflection and the Aero margin turn are exactly the fundamental improvements that should compress a de-rating, and the Solstice execution de-risks the harder Aero spin. We would rather own the re-rating into a proven turn than wait for the spin to complete and pay a higher multiple.
Debate: Is the 2026 Margin-Expansion Story Real?
Bull view: The 2025 margin softness was substantially a tariff-pricing lag plus CAES integration and catalyst timing, all identifiable and reversing. Aero flips price from headwind to tailwind, CAES turns accretive, OE recouples, IA gets backlog leverage, and ESS normalizes catalyst. Management has been specific and consistent about each lever.
Bear view: Every industrial promises next-year margin expansion. The full-year segment-margin guide has been nudged down twice, aftermarket (the highest-margin Aero revenue) is normalizing, and standalone entities lose corporate scale. The 2026 expansion is a hope until it prints.
Our take: Lean bull, with Aerospace already delivering the proof (26.1%, +60bp sequentially). The pricing-lag-reversal logic is mechanical and checkable. We will grade it hard through H1 2026, but the direction and the specificity justify underwriting it now.
Debate: Does the SOTP Unlock Justify Paying Up Before the Aero Spin?
Bull view: Three focused companies, each with tailored capital allocation and a clean balance sheet (post Bendix/Resideo cleanup), should collectively command a higher multiple than the conglomerate's ~19.5x. Solstice executing early proves management can deliver the harder Aerospace spin. Buying before the H2 2026 Aero spin captures the re-rating.
Bear view: Solstice is the smallest, least-consequential piece; the real value is in the Aerospace spin, which is still three quarters away and carries execution risk. Stranded costs are unquantified. Better to wait for the standalone Aerospace framework before underwriting the SOTP.
Our take: The asymmetry favors owning it now. The catalyst path is de-risked (Solstice early, balance sheet cleaned), the fundamental has turned, and the valuation is depressed. We would rather be early to the re-rating than wait for full clarity and pay for it.
Model & Valuation Framework
| Item | Prior (Q2 Recap) | Updated (Q3 Recap) | Reason |
|---|---|---|---|
| FY25 organic growth | +4-5% | ~+6% | Q3 acceleration; orders +22% |
| FY25 adjusted EPS | $10.45–10.65 | $10.60–10.70 | Third raise; absorbs Solstice drag |
| FY26 adjusted EPS (RemainCo) | n/a | ~$10.6–11.0 | Post-Solstice base + margin expansion |
| Forward P/E at $207.91 | ~21.3x | ~19.5x | De-rated; among cheapest in years |
| 12-month PT (base) | $235 | $235 | Re-rate to ~21-22x on FY26 RemainCo + SOTP |
| 12-month PT (bull) | $265 | $255 | Full SOTP unlock; Aero re-rates on standalone framework |
| 12-month PT (bear) | $195 | $185 | Macro/execution setback; de-synergy reveal |
Valuation framework: At $207.91 and FY25 adjusted EPS of $10.60-10.70, HON trades at ~19.5x, a meaningful discount to its own 22-23x history and to quality-industrial peers. On a look-through FY26 RemainCo EPS of ~$10.6-11.0 (post-Solstice, with the margin-expansion levers landing), the base-case PT of $235 assumes a modest re-rating toward 21-22x as the split value crystallizes and the order book converts, implying ~+13% upside. The bull case ($255, ~+23%) requires the standalone Aerospace framework to re-rate that business toward an aerospace multiple and the conglomerate discount to compress materially. The bear case ($185, ~−11%) is a macro/execution setback or an adverse stranded-cost reveal. The up-to-down skew has turned favorable, roughly 2:1 base-to-bear, which is what moves us from Hold to Outperform.
Thesis Scorecard Post-Earnings
Grading the standing thesis established at our July initiation against what Q3 revealed.
| Thesis Point | Status | Notes (change vs. Q2) |
|---|---|---|
| Bull #1: Three-way split unlocks SOTP value | Confirmed (strengthening) | Solstice spins Oct 30 (a quarter early); new segmentation set; Aero leadership/HQ due. ON TRACK → STRENGTHENING |
| Bull #2: Aerospace is a premium standalone franchise | Confirmed | Margin 26.1% (+60bp QoQ), trough confirmed behind; +12% organic; 1.2x book-to-bill. AT RISK → ON TRACK |
| Bull #3: Portfolio-transformation discipline | Confirmed (strengthened) | Bendix + Resideo balance-sheet cleanup; M&A at ~12x ahead of plan; segmentation redesign |
| Bull #4: R&D reinvestment reaccelerates organic growth | Confirmed | Orders +22% broad-based; IA back to growth; "early results of R&D investments." STRENGTHENING |
| Bear #1: Thin clean growth & cut margin guide | Improving | Organic accelerated to +6%; orders inflected. But FY segment-margin guide nudged lower again. EMERGING → CONTAINED |
| Bear #2: Full valuation for the catalyst | Resolving | De-rated to ~19.5x (-14% YTD). Valuation is now a tailwind, not a risk. CONTAINED → largely resolved |
| Bear #3: Separation execution / dis-synergy & macro | Contained | Solstice early + balance sheet de-risked; but stranded costs unquantified, energy/catalyst macro persists |
Overall: Thesis strengthened. Every bull pillar confirmed or strengthening; the two most acute bear points (Aero margin under Bull #2, and valuation under Bear #2) both moved decisively in our favor. The remaining risks (stranded costs, energy macro, cash conversion) are contained and mostly 2026-datable.
Action: Upgrade to Outperform. Own the re-rating into a proven turn. We would move back to Hold on a Q4/Q1 miss on the promised 2026 margin expansion or an adverse stranded-cost reveal; we would consider Underperform only on a demand rollover that reverses the order inflection.
Bottom Line: Upgrading to Outperform
Three months ago we initiated at Hold and named the conditions for an upgrade: prove the Aerospace margin was transitory, and crystallize the split value, at a price that had not already paid for both. Q3 delivered all three. Aerospace margin bottomed and turned up 60bp to 26.1% with the trough explicitly confirmed behind; the order book inflected to +22% and a record $39.1B backlog; Solstice spins in a week, a quarter ahead of plan; and the balance sheet was cleaned of two legacy liabilities. Meanwhile the stock spent the intervening quarter de-rating to ~19.5x, its cheapest in years, after underperforming the S&P by ~28 points YTD.
That combination, a turning fundamental, an inflecting order book, an imminent and de-risked value-unlock, and a depressed valuation, is precisely the asymmetry a Hold was waiting for. The bear points that anchored our caution have either improved (thin growth, now +6% organic with orders inflecting) or resolved (full valuation, now a tailwind). What remains, unquantified stranded costs and an energy/catalyst macro overhang, is contained and 2026-datable.
The risk to the call is straightforward: 2026 is where management has loaded the margin-expansion promise, and the full-year segment-margin guide has been nudged down twice even as EPS rose. If the pricing reset and CAES accretion do not show up in H1 2026 margins, the re-rating stalls. But Aerospace is already delivering the proof, the pricing-lag reversal is mechanical, and the order book de-risks the revenue. We would rather be early to the re-rating than wait for the H2 2026 Aerospace spin and pay up for clarity. Upgrading to Outperform from Hold.